FDA proposes mechanism for disseminating information about off-label uses.
D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004346:Drug Information Services / Q000331:legislation & jurisprudence; D006801:Humans; D008389:Marketing of Health Services / Q000331:legislation & jurisprudence*; D011356:Product Labeling / Q000331:legislation & jurisprudence*; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*